Molecular Pharmacology in Diabetes
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (15 April 2023) | Viewed by 17107
Special Issue Editors
Interests: diabetic retinopathy; neuroinflammation; therapeutics
Special Issues, Collections and Topics in MDPI journals
Interests: gut microbiota; therapeutics and nutraceuticals; cardiovascular and metabolic disorders; renal diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Diabetes is one of the most significant global public health concerns. Poorly controlled diabetes can have severe repercussions in a wide range of organs and tissues of the body, ranging from vascular complications, including retinopathy, nephropathy, and cardiomyopathy, to other diseases such as cancer or neurodegenerative problems. Despite advances in therapeutic strategies to lower glucose levels, some of the complications of diabetes are neither reversible nor preventable. Understanding the molecular signaling pathways underlying diabetes and related complications helps to identify potential new therapeutic targets for the management of those diseases.
This Special Issue invites important and novel advances made on the identification of key molecules and molecular signaling pathways associated with oxidative stress and inflammation in diabetes and related complications that could open up new therapeutic avenues. In addition, state-of-the-art molecular studies on therapeutical options for those diseases are also welcomed, including pre-clinical studies using relevant cellular and animal models, but excluding pure clinic-related research.
Dr. Rosa Fernandes
Dr. Flávio Reis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- vascular complications
- cancer
- neurodegenerative disorders
- key molecular players
- signaling pathways
- molecular biomarkers
- pharmacological agents
- antioxidants
- anti-inflammatory agents